In China, on average, more than 1, people are diagnosed with cancer every day, and 7.5 people are diagnosed with cancer every minute. Among all malignant tumors, lung cancer ranks first in both morbidity and mortality, and the incidence continues to rise. Behind these cold black numbers, the importance of early screening and early diagnosis of lung cancer is highlighted. November is the global lung cancer concern month. On November 9th, the "Power of Lung-219 National Lecture Hall on Lung Cancer Health" sponsored by China Red Cross Foundation was held in Tongzhou Campus of Beijing Friendship Hospital affiliated to Capital Medical University. At the scene of popular science lecture, lung cancer has entered the era of precise treatment, and lung cancer is expected to become a "chronic disease". After decades of unremitting struggle with lung cancer, the level of diagnosis and treatment of lung cancer in China has been greatly improved, and the 5-year survival rate of patients has been greatly improved. Many people have been able to live with cancer for many years, and lung cancer is expected to become a "chronic disease" in the future. Genetic testing can help patients find the target area more effectively, which plays an important guiding role in targeted therapy. Just like cruise missiles, they must have a target, and after they have a target, they can hit very accurately. Fu Yili, deputy chief physician of thoracic surgery department of Beijing Chaoyang Hospital affiliated to Capital Medical University, told the reporter that patients with gene mutations found through genetic testing can benefit more widely, such as EGFR, KRAS, HER-2, etc., among which EGFR is the most common mutant gene. For patients with EGFR mutant lung cancer, the first-generation targeted drugs can effectively prolong the survival time of patients. Now, with many new targets being gradually discovered, second-generation drugs and third-generation drugs are on the market, and more people can benefit. With the emergence of innovative drugs and the development of targeted therapy, the first generation of targeted drug gefitinib was listed in China in 24, which opened the era of accurate diagnosis and treatment of advanced non-small cell lung cancer in China. Since then, the second and third generation of targeted drugs have been approved for listing in China. With the development of targeted innovative drugs and high-tech genetic testing, precision therapy has also made great strides forward, allowing more patients to live with cancer for a long time and greatly improving their quality of life. Five types of people are high-risk groups of lung cancer, and early screening and early diagnosis can not be ignored. If lung cancer can be diagnosed at an early stage, the 5-year survival rate can reach over 9%. However, because the early symptoms of lung cancer are not obvious, 7%-8% of patients are diagnosed at an advanced stage and miss the best treatment opportunity. Liang Naixin, deputy chief physician of the Department of Thoracic Surgery of Peking Union Medical College Hospital, said: The incidence and mortality of lung cancer are rising continuously. How to find, diagnose and treat lung cancer early is the key to improve the curative effect of lung cancer treatment. It can be seen that early screening plays a vital role in the whole process of lung cancer prevention and treatment. In July 219, the Healthy China Action (219-23) issued at the national level listed cancer prevention as one of the 15 major actions, and made important arrangements and plans for cancer prevention, early screening, early diagnosis and treatment, and standardized treatment. Low-dose spiral CT is one of the main methods to find early lung cancer at present. "Han Bing, deputy chief physician of cardiothoracic surgery in China People's Rocket Army Medical Center, stressed that" it is very important to improve the awareness of early screening if lung cancer is to be found early. The following groups are high-risk groups of lung cancer, such as those with smoking index greater than 4 (2 cigarettes a day, smoking history of 2 years), bad cooking habits, long-term living in polluted environment, family history of cancer or chronic lung disease. Low-dose spiral CT screening should be conducted regularly every year. In order to promote the prevention, screening, early diagnosis and early treatment of lung cancer, in addition to raising the awareness of screening, it is necessary to coordinate medical resources at all levels, strengthen cooperation, provide patients with full course management, and promote early diagnosis and early treatment through accurate diagnosis platform. Scientifically understand the prevention and treatment of lung cancer and promote standardized diagnosis and treatment. At the event site, experts also brought wonderful popular science lectures and free clinic activities. Specially invited Han Bing, deputy chief physician of Cardiothoracic Surgery of Rocket Army Characteristic Medical Center, Qian Zhe of Beijing Chest Hospital affiliated to Capital Medical University, Hu Mu, deputy chief physician of Beijing Friendship Hospital affiliated to Capital Medical University, and Cui Yong, deputy director of thoracic surgery affiliated to Capital Medical University, and more than ten experts in the field of lung cancer participated in the activity. Hu Mu, deputy chief physician of the Department of Thoracic Surgery, Beijing Friendship Hospital affiliated to Capital Medical University, said: "As the' first killer of cancer', lung cancer is seriously endangering the lives and health of Chinese residents. However, due to the weak awareness of early screening, many patients failed to find it as early as possible. We hope that through this health science popularization activity, the public's awareness of early screening, early diagnosis and early treatment of lung cancer will be enhanced, and more patients will realize the importance of genetic testing and promote the standardized diagnosis and treatment of lung cancer. Cui Yong, deputy director of the Department of Thoracic Surgery of Beijing Friendship Hospital affiliated to Capital Medical University, said that as the first 3A general hospital in the city's sub-center, in order to better promote the construction of graded diagnosis and treatment and medical complex, improve the construction of medical service system in the city's sub-center, and provide high-quality medical and health guarantee for the construction of the sub-center, Tongzhou Campus has been fully connected with all tertiary and secondary medical resources and some primary medical institutions in Tongzhou District, and is committed to enabling patients to get high-quality services at home, and promoting early screening, early diagnosis and early treatment of lung cancer. ▲ Disclaimer: The above content comes from the Internet, and the copyright belongs to the original author. If there is any infringement of your original copyright, please let us know, and we will delete the relevant content as soon as possible.